Articles. Keynotes. Talks.

Attorney, serial tech founder, and founder of DrAnsay.com. A doctorate-holding lawyer specializing in the intersection of law, technology, and health care. In 2018, Dr. jur. Can Ansay introduced the digital sick note in Germany with au-schein.de and has shaped telemedicine significantly ever since.

An entrepreneur who repeatedly founds and builds technology companies. Dr. jur. Can Ansay has successfully established several digital health and technology projects in the market.

The AI-powered diagnostic app EBMApp, DrAnsay.com — a telemedicine platform with over 700,000 users — and a patented foldable VR headset (Patent DE 102015000354.2).

To democratize access to medical care and remove bureaucratic barriers through digital solutions — fast, straightforward, and patient-centered, beyond established structures.

AI as a driving force for innovation: data-driven decisions, personalized offerings, optimized processes. The vision: intelligent collaboration between humans and machines — AI for repetitive tasks, human creativity for strategy.

Dr. jur. Can Ansay studied law and earned a doctorate (Dr. jur.). He is admitted to the bar and deliberately left his legal career to venture into entrepreneurship and technology development. This unique combination of legal expertise and an entrepreneurial mindset defines him.

A telemedicine platform for digital online prescriptions — from medical cannabis to weight-loss injections and other health services. A medical review is carried out via questionnaire or video consultation; the marketplace includes over 350 pharmacies with more than 1,400 cannabis products.

Yes. The platform operates within the legally permitted framework of telemedicine and works with licensed physicians who review each case individually. Since partial legalization on April 1, 2024, medical cannabis has been governed by the Cannabis Act (CanG) — with less bureaucracy and faster access.

DrAnsay.com offers a time-saving, discreet, and straightforward alternative to the traditional doctor’s office. The entire process — from prescription request to medical review to pharmacy selection — is handled digitally. Patients with chronic conditions or clear indications can address their treatment needs quickly and without waiting times. The platform also provides access to a broad pharmacy network with price comparison and a best-price guarantee. For many, this flexibility is a decisive everyday advantage.

In 2013, Dr. jur. Can Ansay deliberately left his legal career to realize innovative health solutions. He sees himself as a champion of freedom and self-determination — driven by the desire to bring creative ideas to life and effect positive social change.

In 2018, Dr. jur. Can Ansay introduced the digital sick note — a first at the time. With DrAnsay.com, he has since built a broad telemedicine portfolio and contributed significantly to establishing telemedicine in Germany.